Abstract
Agonists of CC chemokine receptor CCR1 contribute to the pathogenesis of autoimmune and other inflammatory diseases, possibly via the regulation of the transcription factor NF-κB. CCR1 and CCR2b have been demonstrated to use PTX-insensitive Gα14 and Gα16 to stimulate PLCβ in cotransfected cells, and Gα14 and Gα16 are capable of activating NF-κB. The coexpression of Gα14, Gα16, and CCR1 in human monocytic THP-1 cells suggests that CCR1 may use Gα14 or Gα16 to induce NF-κB activation. Here, we demonstrated that a CCR1 agonist, Lkn-1, stimulated NF-κB phosphorylation via PTX-insensitive G proteins in THP-1 cells. Lkn-1 also mediated IKK/NF-κB phosphorylations in HEK293 cells overexpressing CCR1 and Gα14/16. Using various kinase inhibitors, Raf-1, MEK1/2, PLCβ, PKC, CaM, CaMKII, and c-Src were found to participate in Lkn-1-stimulated IKK/NF-κB phosphorylations in THP-1 and transfected HEK293 cells. Although c-Jun N-terminal kinase and p38 MAPK were activated by Lkn-1, they were not required in Lkn-1-induced IKK phosphorylation. The ability of CCR1 to signal through Gα14/16 thus provides a linkage for chemokines to regulate NF-κB-dependent responses.

This publication has 63 references indexed in Scilit: